Purchase Order 75N95021P00697

The National Institute on Drug Abuse issued a purchase order to Life Technologies Corporation valued at $16,804.50 on September 14, 2021, for cell culture media including STEMFLEX Medium Combo Kits, Essential 8 Medium Kits, and STEMPRO NSC SFM Kits. Performance occurs in Carlsbad, California. The order was issued to de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) prior to the September 30, 2026 close of the period of availability....

<p>The National Institute on Drug Abuse awarded a purchase order to Life Technologies Corporation for $16,990.88 on July 30, 2019. The order carries no set-aside designation and has a firm fixed price structure. Performance takes place in Carlsbad, California. The ultimate completion date is July 31, 2022. The order is part of the FY26 UDO Initiative.</p>

The National Institute on Drug Abuse issued a purchase order to Life Technologies Corporation on September 21, 2022, for $57,524.81 under a firm fixed-price arrangement. Performance is located in Carlsbad, California. The order was issued in response to a solicitation posted September 7, 2022, with a due date of September 13, 2022. Ultimate completion is scheduled for October 30, 2022. No set-aside was applied. The award covers commercial scientific equipment, reagents, consumables, or related...

The National Institute on Drug Abuse issued a purchase order to Life Technologies Corporation valued at $43,171.69 on December 14, 2018, for service contract renewal, with an ultimate completion date of December 13, 2021. This is a firm fixed price, no-set-aside simplified acquisition. Place of performance is Carlsbad, California. The order was issued to de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in preparation for the September...

<p>The National Institute on Drug Abuse awarded a purchase order to Life Technologies Corporation for a magnetic particle processor for nucleic acid and protein purification systems on August 5, 2021, with a ceiling value of $70,975.00. Performance occurs in Bronx, New York. The order is firm fixed price with an ultimate completion date of August 5, 2022. The originating pre-solicitation was posted July 12, 2021, with a due date of July 19, 2021.</p>

<p>The National Institute on Drug Abuse awarded a purchase order to Qiagen, LLC on September 16, 2021, with a firm fixed price ceiling value of $24,943.02 to administratively de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a). Place of performance is Baltimore, Maryland. The order's ultimate completion date was October 16, 2021.</p>

<p>The National Institute on Drug Abuse issued a purchase order to Hamilton Company for an automated cell culture processing system valued at $1,229,233.40, awarded August 27, 2021, with ultimate completion June 10, 2022. The order was issued under firm fixed-price terms to de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a). Place of performance is Reno, Nevada. No small business set-aside was used.</p>

<p>The National Institute on Drug Abuse issued a purchase order to Phenomenex, Inc. on September 8, 2021, valued at $10,591.45 for administrative de-obligation of unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a), with ultimate completion on October 8, 2021. Place of performance is Baltimore, Maryland. The order is firm fixed price with no set-aside.</p>

The National Institute on Drug Abuse issued a purchase order to Government Scientific Source Inc., a small business, for $9,679.68 on February 18, 2021. The order was firm fixed price with no set-aside designation. Place of performance was Baltimore, Maryland. The purchase order was issued to administratively de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in preparation for the September 30, 2026 closing of the period of availability...

The National Institute on Drug Abuse awarded a purchase order to Eurofins Discoverx LLC for $24,293.10 in testing compounds on September 17, 2021, with ultimate completion on September 17, 2022. The order was issued as a firm fixed price acquisition to de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a), in preparation for the September 30, 2026 closing of fund availability. Work is performed in Fremont, California. No set-aside was used.